![Jay Luly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Luly
Algemeen Directeur bij
ENANTA PHARMACEUTICALS, INC.
Vermogen: 11 M $ op 31-05-2026
Profiel
Jay R.
Luly is President, Chief Executive Officer & Director at Enanta Pharmaceuticals, Inc. since 2003.
Former positions include Director at Artesian Therapeutics, Inc., Senior Vice President-Drug Discovery & Pre-Clinical Development at Abbott Laboratories from 1983 to 1997, Senior Vice President-Research & Development Operations at Millennium Pharmaceuticals, Inc., Senior Vice President-Drug Discovery & Preclinical Development at LeukoSite, Inc., and Trustee at The Boston Biomedical Research Institute.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Illinois.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-02-2026 | 871.871 ( 3% ) | 11 M $ | 31-05-2026 |
Actieve functies van Jay Luly
| Bedrijven | Functie | Begin |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Algemeen Directeur | 01-07-2003 |
Eerdere bekende functies van Jay Luly
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Hoofd Techniek/Wetenschap/O&O | - |
The Boston Biomedical Research Institute | Directeur/Bestuurslid | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical therapeutic products | Directeur/Bestuurslid | - |
Opleiding van Jay Luly
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
71
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical therapeutic products | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The Boston Biomedical Research Institute |
